AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • December 26th, 2023 • Atreca, Inc. • Pharmaceutical preparations • California
Contract Type FiledDecember 26th, 2023 Company Industry JurisdictionTHIS AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”) is entered into as of December 19, 2023, (the “Effective Date”) by and between Atreca, Inc. (the “Company”), and Tito A. Serafini, Ph.D. (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
ASSET PURCHASE AGREEMENT by and between Atreca, Inc. and Immunome, Inc. Dated as of December 22, 2023Asset Purchase Agreement • December 26th, 2023 • Atreca, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 26th, 2023 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”) is made and executed as of December 22, 2023 (the “Execution Date”), by and between Atreca, Inc., a Delaware corporation (“Seller”) and Immunome, Inc., a Delaware corporation (“Purchaser”). Seller and Purchaser are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”